JG

Jeff Goater

Partner at The Column Group

Greater Boston

Investor
VC
CEO

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Corporate Finance
Start-ups
Corporate Development
Valuation
Mergers & Acquisitions
Due Diligence
Business Development
Licensing
Venture Capital
Investment Banking
M&A experience
Emerging Markets
Private Equity
IPO
Financial Modeling
Biotechnology

Education

Investments

Kenai Therapeutics

Series A

Total Funding: $82M

Atavistik Bio

Series A

Total Funding: $100M

Work Experience

Topo Therapeutics

2024

  • Board Member

    2024

NILO Therapeutics

2024

  • Board Member

    2024

Kenai Therapeutics

2024

  • Board Member

    2024

The Column Group

2021

  • Partner

    2024

  • Venture Partner

    2021 - 2023

Remix Therapeutics

2023

  • Board Member

    2023

AviadoBio

2023

  • Chair

    2023

Stealth Biotech Company

2022

  • Executive Chair

    2022

Kallyope

2022

  • Board Member

    2022

Atavistik Bio

2021

  • Board Member

    2021

  • Interim CEO

    2022 - 2023

Ribon Therapeutics

2021 - 2024

  • Board Member

    2021 - 2024